Process for phenylacetic acid derivatives
Abstract
A process for the production of a compound of Formula I, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable prodrug ester thereof, comprising cleaving a lactam of formula II wherein the symbols are as defined, with a base; and precursors therefor and processes for the preparation of the precursors. The compounds of Formula I are pharmaceutically active compounds which are selective inhibitors of Cyclooxygenase II.
Claims
exact text as granted — not AI-modified1 . process for the production of a compound of Formula I, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable prodrug ester thereof,
wherein R is methyl or ethyl;
R 1 is chloro or fluoro;
R 2 is hydrogen or fluoro;
R 3 is hydrogen, fluoro, chloro, methyl, ethyl, methoxy, ethoxy or hydroxy;
R 4 is hydrogen or fluoro; and
R 5 is chloro, fluoro, trifluoromethyl or methyl,
provided that R 1 , R 2 , R 4 and R 5 are not all fluoro when R is ethyl and R 3 is H; comprising cleaving a lactam of formula II
wherein the symbols are as defiled above with a base; and in the above process, if desired, temporarily protecting any interfering reactive groups and then isolating the r in compound of the invent; and, if desired, converting the free carboxylic acid of the compound of formula I into a pharmaceutically acceptable ester derivative thereof; and/or if desired, converting the free acid of formula I into a salt or a resulting salt into the free acid or into another salt.
2 . A process selected from
a) a process for the production of a lactam of formula II
which comprises oxidizing of a lactam of formula II
b) a process for the production of the lactam of formula II as defined in a) above, which comprises cyclisation of a compound of formula VII
c) a process for the preparation of a compound of formula III as defined above comprising coupling as aniline derivative of formula IV
with a cyclohexanone derivative of formula Va or an amino substituted cyclohexene derivative of formula Vb
wherein R is ethyl or methyl and R′ is lower alkyl or similar or NR′ 2 forms a ring as in piperidine or morpholine.
d) a process for the production of a compound of formula VII which comprises N-acylation of a diphenylamine of formula VIII
with a haloacetyl chloride
e) a process for the preparation of a compound of formula VIII which comprises rearrangement and hydrolysis of a compound of formula IX.
f) a process for the production of a compound of formula VIII which comprises coupling of a halobenzene derivative of formula XI with p-toluidine or 4-ethyl-aniline
where X is a halogen
g) a process for the production of a compound of formula VIII as defined in d) above which comprises coupling an aniline derivative of formula IV as defined in c) above with 4-bromotoluene or 1-ethyl-bromobenzene
h) a process for the production of a compound of formula VIII as defined in d) above which comprises cleavage of a compound of formula X
i) a process for the formation of a compound of formula X as defined in h) above which comprises rearrangement of a compound of formula IX as defined in e) above
j) a process for the product of a compound of formula IX as defined in e) above with comprises alkylation of a compound of formula XII
with 2-chloro-N-(4-methylphenyl)acetamide or 2 chloro-N-(4-ethylphenyl)acetamide
k) a process for the production of a compound of formula VIII as defined in d) above which comprises alkylation of a compound of formula XII as defined in j) above with 2-chloro-N-(4-methylphenyl)acetamide or 2 chloro-N-(4 ethylphenyl)acetamide followed by rearrangement and cleavage
l) a process for the production of a compound of formula VIII as defined in d) above comprising oxidation of the corresponding compound of formula XIII (or a tautomer thereof)
m) a process for the production of a compound of formula XIII as defined in l) above which comprises coupling 1-methoxy-4-methylcyclohexa-1,4-diene or 1-methoxy-4-ethylcyclohexa-1,4-diene with an aniline derivative of formula IV as defined in c) above, and
n) a process for the production of a compound of formula VIII as defined in d) above con-sing coupling 1-methoxy-4-methylcyclohexa-1,4-diene or 1-methoxy-4-ethylcyclohexa-1,4-diene with an aniline derivative or formula IV as defined in c) above, followed by oxidation,
wherein the symbols are as defined in claim 1 .
3 . A process for the preparation of a compound of formula I as defined in claim 1 .
which comprises one or more of processes a) to n) as defined in claim 2 and optionally a process according to claim 1 .
4 . A process according to claim 3 for the preparation of a compound selected from:
5-methyl-2-(2′,4′-dichloro-6′-methylanilino)phenylacetic acid;
5-methyl-2-(2′, 3′, 5′,6′-tetrafluoroanilino)phenylacetic acid;
5-methyl-2-(2′, 3′, 4′,6′-tetrafluoroanilino)phenylacetic acid;
5-methyl-2-(2′,6′-dichloroanilino)phenylacetic acid;
5-methyl-2-(2′,6′-dichloroanilino)phenylacetic acid, potassium salt;
5-methyl-2-(2′,6′-dichloroanilino)phenylacetic acid, sodium salt;
5-methyl-2-(2′-chloro-6′fluoroanilino)phenylacetic acid;
5-methyl-2-(2′,6′-dichloro-4′-methylanilino)phenylacetic acid;
5-methyl-2-(2′-chloro-6′-methylanilino)phenylacetic acid;
5-methyl-2-(2′,4′-difluoro-6′-chloroanilino)phenylacetic acid;
5-methyl-2-(2′-fluoro-4′,6′-dichloroanilino)phenylacetic acid;
5-methyl-2-(2′-chloro-4′-fluoro-6′-methylanilino)phenylacetic acid;
5-methyl-2-(2′-fluoro-6′-chloroanilino)phenylacetic acid;
5-ethyl-2-(2′-chloro-6′-methylamino)phenylacetic acid;
5-ethyl-2-(2′,3′,6′-trifluroanilino)phenylacetic acid;
5-ethyl-2-(2′,3′,5′,6′-tetrafluoro-4′-ethoxyanilino)phenylacetic acid;
5-ethyl-2-(2′,3′,5′,6′-tetrafluoro-4′-ethoxyanilino)phenylacetic acid;
5-ethyl-2-(2′-chloro-4′,6-difluoroanilino)phenylacetic acid;
5-ethyl-2-(2′,4′-dichloro-6′-fluoroanilino)phenylacetic acid;
5-ethyl-2-(2′,4′-dichloro-6′-methylamino)phenylacetic acid;
5-ethyl-2-(2′-fluoro-4′-chloro-6′-methylanilino) phenylacetic acid;
5-ethyl-2-(2′,4′-difluoro-6′-methylanilino)phenylacetic acid
5-ethyl-2-(2′-chloro-4′-fluoro-6′-methylanilino)phenylacetic acid;
5-methyl-2-(2′-chloro-4′-hydroxy-6′-fluoroanilino)phenylacetic acid;
5-methyl-2-(2′-fluoro-6′-trifluoromethylanilino)phenylacetic acid, and
5-methyl-2-2′,4′-dichloro-6′-trifluoromethylanilino)phenylacetic acid, and pharmaceutically acceptable salts thereof; and pharmaceutically acceptable prodrug esters thereof.
5 . A process according to claim 3 for the preparation of a compound selected from:
5-methyl-2-(2′, 3′, 4′,6′-tetrafluoroanilino)phenylacetic acid;
5-methyl-2-(2′,6′-dichloroanilino)phenylacetic acid;
5-methyl-2-(2′-chloro-6′-fluoroanilino)phenylacetic acid;
5-methyl-2-(2′,6′-dichloro-4′-methylanilino)phenylacetic acid;
5-methyl-2-(2′-chloro-6′-methylanilino)phenylacetic acid;
5-methyl-2-(2′-chloro-4′-fluoro-6′-methylanilino)phenylacetic acid;
5-ethyl-2-(2′-fluoro-6′-chloroanilino)phenylacetic acid;
5-ethyl-2-(2′-chloro-6′-methylanilino)phenylacetic acid;
5-ethyl-2-(2′,3′,6′-trifluroanilino)phenylacetic acid, and
5-ethyl-2-(2′,4′-dichloro-6′-methylanilino)phenylacetic acid,
and pharmaceutically acceptable salts thereof; and pharmaceutically acceptable prodrug esters thereof.
6 . A compound of formula I, as defined in claim 1
or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable prodrug ester thereof, when prepared by a process as defined in claim 3 .
7 . A compound selected from
a) a compound of formula II
b) a compound of formula III
c) a compound of formula VII
d) a compound of formula VIII
e) a compound of formula IX
f) a compound of formula X
or
g) a compound of formula XIII
wherein the symbols are as defined in claim 1 .Join the waitlist — get patent alerts
Track US2008249318A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.